Drug Type Small molecule drug |
Synonyms SIM0272 |
Target |
Action inhibitors |
Mechanism PRMT5 inhibitors(Protein arginine methyltransferase 5 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | China | 15 Jun 2022 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | China | 18 May 2022 | |
| Non-Hodgkin's lymphoma refractory | Phase 1 | China | 18 May 2022 | |
| Non-Small Cell Lung Cancer | Phase 1 | China | 18 May 2022 | |
| Neoplasms | IND Approval | China | 13 Jan 2022 |
Phase 1 | 21 | xcaxetgttj(yhwwegrqpb) = zngfhcqikl frjtnmmldk (fhykcxvqtk ) View more | Positive | 23 Oct 2023 |





